September 6, 2023
Breakthrough platform delivers process flexibility and scalability with the first active release mechanism of its kind for clinical trial and commercial manufacturing use WALTHAM, Mass.– Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)*, its next-generation platform of Dynabeads with the first active release mechanism of its [...]
September 6, 2023
HALLE (SAALE), Germany and BARCELONA, Spain -- We are excited to announce a pioneering partnership between Nostrum Biodiscovery, a frontrunner in computational molecular engineering services, and Navigo Proteins, an innovator developing next generation targeting ligands called Affilin®. Navigo and Nostrum recently joined forces to co-develop a new cutting-edge pipeline of de novo designed ubiquitin-based Affilin® ligands, expanding Navigo’s proprietary Affilin® [...]
September 6, 2023
Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays Pre-validated cells alleviate the need for stringent in-house quality control testing to maximize assay success Cambridge, UK: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, “LifeNet Health”, [...]
iotaSciences and Quantum Design China Enter into Distribution Agreement
September 6, 2023
Exclusive partnership will provide access for customers in China to iotaSciences proprietary single cell handling platforms based on its proprietary fluid-shaping technology Oxford (UK): iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, and Quantum Design China, a subsidiary of Quantum Design International, announced today an exclusive distribution agreement for iotaSciences [...]
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
September 6, 2023
ROCKVILLE, Md. -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the appointment of Ali Soleymannezhad as Executive Vice President of Bioprocessing, effective August 21, 2023. Mr. Soleymannezhad will [...]
Tecan and PacBio: high accuracy, automated long-read sequencing to accelerate discovery in genomics
September 5, 2023
Männedorf, Switzerland – Tecan and PacBio are collaborating to automate genomics research, with a focus on high accuracy, long-read DNA sequencing. A new, automated workflow for medium and high throughput DNA library prep – which combines Tecan’s DreamPrep® NGS Compact or DreamPrep NGS automation platforms with PacBio’s SMRT® library prep reagents – streamlines the path [...]
September 5, 2023
IVIS® Spectrum 2 and IVIS SpectrumCT 2 imaging systems — new flagship platforms setting the standard in high-throughput performance and versatility QuantumTM GX3 microCT imaging solution — a high-throughput system with superior spatial resolution and fast, low-dose scanning for diverse in vivo and biological ex vivo applications Vega® preclinical ultrasound system — a hands-free, automated, high-throughput imaging system delivering high-resolution 2D and 3D [...]
SomaLogic expands agreement with Novo Nordisk to 2025
September 5, 2023
Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases BOULDER, Colo. -- SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk. As part of the agreement, which now extends into the end of [...]
Illumina’s Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer
September 5, 2023
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief Executive Officer, effective September 25, 2023. Mr. Thaysen's extensive [...]
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group
September 5, 2023
SANTA CLARA, Calif. -- Agilent Technologies, Inc. (NYSE: A) today announced Philip Binns has been named president of the company’s Life Sciences and Applied Markets Group (LSAG). Binns previously served as vice president and general manager of the Spectroscopy and Vacuum division for LSAG. Binns replaces Jacob Thaysen who left the company effective today. “We’re [...]

